Roche CEO Severin Schwan said: “The first half of this year, both Pharmaceutical and Diagnostic divisions had a good growth for sales, in all the regions where we operate. In this period we have successfully launched our first medicinal product of immunotherapy in oncology”.
For more information, please see the Romanian version of the article, here.